Literature DB >> 10380050

EORTC classification for primary cutaneous lymphomas: the best guide to good clinical management. European Organization for Research and Treatment of Cancer.

R Willemze1, C J Meijer.   

Abstract

In 1997 the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer (EORTC) published a proposal for a classification for the group of primary cutaneous lymphomas (1). The EORTC classification is the first and only classification that is designed exclusively for the group of primary cutaneous lymphomas. It is also the only classification that has been clinically validated for this group of diseases. As illustrated by this special issue, this classification has resulted not only in the discussion of the definition and terminology of some types of cutaneous T-cell lymphoma (CTCL) and cutaneous B-cell lymphoma (CBCL), but also in a discussion of whether organ-based classification schemes (separate from existing hematopathologic classification schemes for non-Hodgkin lymphomas) should be used. This article explains why it was necessary to create a separate classification for the group of primary cutaneous lymphomas. A short introduction on the history of the classification of cutaneous lymphomas is provided. Next, the basic principles of the EORTC classification are presented. Finally, controversies between the EORTC classification versus the REAL classification (2) and the proposed WHO classification (3), which still impede the usage of one common classification system, are discussed.

Entities:  

Mesh:

Year:  1999        PMID: 10380050     DOI: 10.1097/00000372-199906000-00011

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  5 in total

Review 1.  Signal transducer and activator of transcription (STAT) signalling and T-cell lymphomas.

Authors:  Tracey J Mitchell; Susan John
Journal:  Immunology       Date:  2005-03       Impact factor: 7.397

2.  Diffuse large B-cell lymphoma mimicking advanced basal cell carcinoma.

Authors:  Emmanuel Akinyemi; Le Mai; Abu Matin; Archana Maini
Journal:  J Natl Med Assoc       Date:  2007-08       Impact factor: 1.798

Review 3.  [WHO classification and clinical spectrum of cutaneous lymphomas].

Authors:  C Mitteldorf; S Grabbe; R Stadler
Journal:  Hautarzt       Date:  2017-09       Impact factor: 0.751

4.  Primary cutaneous B-cell lymphoma successfully treated with highly active antiretroviral therapy alone: a case report and review of the literature.

Authors:  María F Villafañe; Marcelo Corti
Journal:  Indian J Dermatol       Date:  2011-07       Impact factor: 1.494

Review 5.  Total skin electron irradiation techniques: a review.

Authors:  Tomasz Piotrowski; Piotr Milecki; Małgorzata Skórska; Dorota Fundowicz
Journal:  Postepy Dermatol Alergol       Date:  2013-02-20       Impact factor: 1.837

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.